Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 304 shares at $3.00 ($912) on 2021-12-02, disclosed to the SEC on 2021-12-03.
Tax-driven sale ($912) by See Remarks — typically RSU/option vesting with shares sold to cover withholding tax. Not a directional view.
Negative factors outweigh the positive ones.
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |